コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 specific genes during the differentiation of myeloid progenitor cells.
2 orresponding to the two alternative fates of myeloid progenitor cells.
3 of gene expression in primary human CD15(+) myeloid progenitor cells.
4 nulocytic differentiation in these and other myeloid progenitor cells.
5 d1 is greater in mature granulocytes than in myeloid progenitor cells.
6 ll proliferation by overexpressing it in 32D myeloid progenitor cells.
7 expressed the c-Maf cDNA in 2 bipotent human myeloid progenitor cells.
8 -delta and -epsilon individually in the 32D myeloid progenitor cells.
9 g of diverse leukocytes and proliferation of myeloid progenitor cells.
10 ony growth of autologous CML blast cells and myeloid progenitor cells.
11 or to control leukemogenic transformation in myeloid progenitor cells.
12 optosis of interleukin 3 (IL-3)-deprived 32D myeloid progenitor cells.
13 ferentiation, survival, and proliferation of myeloid progenitor cells.
14 ibit the granulocytic differentiation of 32D myeloid progenitor cells.
15 of pre-B cells, but to have no influence on myeloid progenitor cells.
16 cDNAs were transfected and expressed in 32D myeloid progenitor cells.
17 ntiation of autonomously proliferating HL-60 myeloid progenitor cells.
18 by the proliferation of a malignant clone of myeloid progenitor cells.
19 ignancy characterized by clonal expansion of myeloid progenitor cells.
20 racterized by the (oligo)clonal expansion of myeloid progenitor cells.
21 ssion and Pol II promoter occupancy in human myeloid progenitor cells.
22 ved in IL-4/IL-13 signaling, mast cells, and myeloid progenitor cells.
23 ative cell surface marker of committed brain myeloid progenitor cells.
24 he gene encoding Fanconi C (Fancc) in murine myeloid progenitor cells.
25 and Ig synthesis, and enhances maturation of myeloid progenitor cells.
26 and short-term hematopoietic stem cells and myeloid progenitor cells.
27 d a growth advantage over wild-type HOXB4 in myeloid progenitor cells.
28 n of Fap1 with the Apc complex in Bcr-abl(+) myeloid progenitor cells.
29 genes that are activated by beta-catenin in myeloid progenitor cells.
30 gene expression in T cells, mast cells, and myeloid progenitor cells.
31 e properties of the Pu/Gata toggle switch in myeloid progenitor cells.
32 iption factor that is maximally expressed in myeloid progenitor cells.
33 ow previously to inhibit colony formation by myeloid progenitor cells.
34 ormal and transformed hematopoietic stem and myeloid progenitor cells.
35 that Tregs can affect the differentiation of myeloid progenitor cells.
36 ic and carcinogenic species in human CD34(+) myeloid progenitor cells.
37 ed fewer nucleated cells and was enriched in myeloid progenitor cells.
38 e GAS2 promoter and repress transcription in myeloid progenitor cells.
39 g to monocyte/DC lineage commitment of human myeloid progenitor cells.
40 ss of Notch-dependent signal transduction on myeloid progenitor cells.
41 tion factor HoxA10 is maximally expressed in myeloid progenitor cells.
42 ered in these leukemias compared with normal myeloid progenitor cells.
44 marily attributable to autonomous defects in myeloid progenitor cells, although the hematopoietic mic
45 eletion of 2 alleles of p53 rescued both the myeloid progenitor cell and long-term hematopoietic stem
46 induces a select set of micro-RNAs (miR) in myeloid progenitor cells and AML patients with t(8;21).
47 (MDS) at 24 months of age, with dysplasia of myeloid progenitor cells and anemia with abnormal circul
48 ement of adhesion between BCR/ABL-expressing myeloid progenitor cells and bone marrow stroma may be o
49 ignaling pathway, we observed an increase in myeloid progenitor cells and CDllb(lo)Gr1(lo) promyelocy
50 expression of HoxA10 is maximal in committed myeloid progenitor cells and decreases as differentiatio
51 GF2 promoter that are activated by HoxA10 in myeloid progenitor cells and differentiating phagocytes.
52 AcmvIL-10 during latent infection of primary myeloid progenitor cells and found that LAcmvIL-10 is re
55 , a CC chemokine, is a specific inhibitor of myeloid progenitor cells and is the most potent activato
56 support interleukin-3-independent growth of myeloid progenitor cells and long-term outgrowth of B-ly
57 survival of preleukemic short-term HSCs and myeloid progenitor cells and maintains the differentiati
58 lso typically TRAF-3 immunonegative, whereas myeloid progenitor cells and megakaryocytes were often T
59 is also expressed during latent infection of myeloid progenitor cells and monocytes and facilitates p
60 OPN (iOPN) diminished the population size of myeloid progenitor cells and myeloid cells, and secreted
61 letion analysis of TLS-ERG in both mouse L-G myeloid progenitor cells and NIH 3T3 fibroblasts reveale
63 xpression of mouse Gr-1(+) and human CD15(+) myeloid progenitor cells and showed that the pattern of
64 romoted the outgrowth of Ly6C(+) and Ly6G(+) myeloid progenitor cells and their mobilization to tumor
65 fied LYL1 promoter showed strong activity in myeloid progenitor cells and was bound in vivo by Fli1,
66 pa was associated with a marked reduction in myeloid progenitor cells, and Gabpalpha null myeloid cel
67 and survival of hematopoietic stem cells and myeloid progenitor cells, and increased Fgf2-expression
68 s a role regulating programmed cell death in myeloid progenitor cells, and that its down-regulation i
69 ative capacity and self-renewal potential of myeloid progenitor cells; and support the hypothesis tha
70 that HoxA9 repressed ARIH2 transcription in myeloid progenitor cells, antagonizing the effect of Hox
71 all RNAs, termed microRNAs, encoded by human myeloid progenitor cells are capable of repressing a key
72 (-/-) and Glc-6-PT(-/-) mice, the numbers of myeloid progenitor cells are increased, while in the ser
73 ated by up to 4 h in AML-1B-expressing 32D.3 myeloid progenitor cells as compared with control cells
74 XC chemokine, were enhanced with bone marrow myeloid progenitor cells as well as macrophages, T cells
75 ted C57BL/6 mice, we observed a reduction in myeloid progenitor cells, as defined both phenotypically
76 ting proliferation and enhancing survival of myeloid progenitor cells at concentrations as low as 3 n
78 g receptor family and is expressed highly on myeloid progenitor cells but at much lower levels in dif
79 tro phenotypes observed with loss of Gfi1 in myeloid progenitor cells but did not rescue Gfi1-/- bloc
80 air of our bones are formed from bone marrow myeloid progenitor cells by a complex differentiation pr
81 ICSBP inhibits growth of Bcr/Abl-transformed myeloid progenitor cells by activating several genes tha
82 interleukin-6 receptor (IL-6R) expression on myeloid progenitor cells by Delta-1 treatment combined w
83 and F1009/F1021 were overexpressed in FDC-P2 myeloid progenitor cells by retroviral-mediated gene tra
85 tological malignancy derived from neoplastic myeloid progenitor cells characterized by abnormal clona
86 nimals bear distorted hematopoietic stem and myeloid progenitor cell compartments compared with euplo
87 IRS-4, we expressed them individually in 32D myeloid progenitor cells containing the human insulin re
88 these findings reveal that Prom1-expressing myeloid progenitor cells contribute to the generation of
89 by colony-forming assays (for erythroid and myeloid progenitor cells), cytochemical staining, and mi
90 cell production or runting but corrected the myeloid progenitor cell deficiency seen in these mutants
91 s (AAV) vectors to transduce primitive human myeloid progenitor cells derived from marrow and cord bl
92 neovasculogenesis and that CD133(+)CXCR4(+) myeloid progenitor cells directly participate in new blo
93 vered that human embryonic stem cell-derived myeloid progenitor cells display a similar engraftment p
95 ly regulates the maturational advancement of myeloid progenitor cells during transitions between two
96 ll development, the gene was introduced into myeloid progenitor cells established from ICSBP-/- mice.
100 y increases atherogenesis through regulating myeloid progenitor cell expansion and differentiation, f
101 d CD34(+)KIT(+) cells, which are enriched in myeloid progenitor cells, expressed and secreted the CCR
102 roarray gene expression analysis of Irf-8-/- myeloid progenitor cells expressing an IRF-8/estrogen re
104 w here that hnRNP A1 levels are increased in myeloid progenitor cells expressing the p210(BCR/ABL) on
105 ew growth factors from IL-3-dependent murine myeloid progenitor cells (factor dependent cell progenit
106 cellularity of the bone marrow, elevation of myeloid progenitor cell frequencies in both organs and a
107 nalysis of gene expression (SAGE) on CD15(+) myeloid progenitor cells from 22 AML patients who had fo
108 okines in a manner similar to that of normal myeloid progenitor cells from bone marrow and cord blood
109 d expression of Fap1 and Gas2 in bone marrow myeloid progenitor cells from Icsbp(-/-) mice in compari
110 results document selective insensitivity of myeloid progenitor cells from mIL-8Rh(-/-) mice to inhib
114 n of KLF7 results in a marked suppression of myeloid progenitor cell growth and a loss of short- and
115 ogenitor cells and may also be necessary for myeloid progenitor cell growth in a variety of hematopoi
117 and critical matrix-degrading activities of myeloid progenitor cells in an autocrine manner by augme
118 vival and abnormal cell cycle progression of myeloid progenitor cells in both cyclic and severe conge
120 rated an inhibitory effect on hemopoiesis of myeloid progenitor cells in colony formation assays.
121 peripheral blood, and the numbers of porcine myeloid progenitor cells in marrow, were increased in co
124 LHRHa), increases the number of lymphoid and myeloid progenitor cells in the bone marrow and developi
126 ncer, we have shown that bone marrow-derived myeloid progenitor cells in the premetastatic lung secre
127 itment of bone marrow-derived CD11b(+)Gr1(+) myeloid progenitor cells in the premetastatic lungs.
129 arrest in lymphopoiesis and the expansion of myeloid progenitor cells in TSLP transgenic mice suggest
131 lso determined that HoxA10 overexpression in myeloid progenitor cells increased Tgfbeta2 production b
132 on of the CML-related Bcr-abl oncoprotein in myeloid progenitor cells increases expression of Fas-ass
133 vere anemia and thrombocytopenia and expands myeloid-progenitor cells, indicating that FOG-1 is requi
134 sed Fgf2 production by HoxA10-overexpressing myeloid progenitor cells induced a phosphoinositol 3-kin
135 Enforced expression of Id1 in committed myeloid progenitor cells inhibits granulocyte but not ma
136 addition, the regeneration of erythroid and myeloid progenitor cells is delayed during stress hemato
137 3-mediated cleavage of cyclin A in dividing myeloid progenitor cells is important for the onset of d
139 e myeloid-derived suppressor cells, immature myeloid progenitor cells known for immunosuppressive pro
140 e growth factor I receptor (IGF-IRWT) in 32D myeloid progenitor cells led to cell proliferation in re
141 To study these pathways, we have used a myeloid progenitor cell line (32D) which is dependent on
142 erence analysis (RDA) to compare a committed myeloid progenitor cell line (EPRO) with the multipotent
143 t proliferation of the IL-3-dependent murine myeloid progenitor cell line 32D is suppressed by human
144 ivation of STAT3-p27(Kip1) pathway in murine myeloid progenitor cell line 32D-G-CSFR cells was marked
145 esponse nor affects the proliferation of the myeloid progenitor cell line 32D-GR that is deficient in
148 ide (DMSO) to induce apoptosis in the murine myeloid progenitor cell line 32Dcl3, we examined the eff
149 y we have sought to characterize a committed myeloid progenitor cell line in an attempt to isolate ge
150 in the human pre-B-cell line 697, the human myeloid progenitor cell line K562, and the murine fibrob
151 ion library derived from the B6SutA(1) mouse myeloid progenitor cell line to search for novel oncogen
152 phages, and ectopic expression of VentX in a myeloid progenitor cell line triggered its differentiati
153 over-expressed in the IL-3 dependent, murine myeloid progenitor cell line, 32D cl3 in order to test w
155 Expression of exogenous Fms in a murine myeloid progenitor cell line, FDC-P1 (FD-Fms), results i
159 fection on MHC class II in Kasumi-3 cells, a myeloid-progenitor cell line that endogenously expresses
160 We established conditionally immortalised myeloid progenitor cell lines co-expressing constitutive
161 ematopoietic growth factor-dependent, lympho-myeloid progenitor cell lines from the fetal livers of b
163 the development of bipotent cells using two myeloid progenitor cell lines, KG-1 and KG-1a, as models
166 When transformed with p210 Bcr/Abl, ICSBP-/- myeloid progenitor cells lost growth factor dependence a
167 onsils; (b) mature neutrophils (high) versus myeloid progenitor cells (low) in bone marrow; (c) corpu
169 strate that a population of adult BM-derived myeloid progenitor cells migrated to avascular regions o
173 ation of hematopoietic stem cells (HSCs) and myeloid progenitor cells (MPCs) has been shown to mediat
174 enhances proliferation of mature subsets of myeloid progenitor cells (MPCs), suppresses proliferatio
175 study, we examined the capacity of malignant myeloid progenitor cells of patients in the chronic phas
176 n to Ba/F3 murine pro-B cells but not to 32D myeloid progenitor cells or CTLL-2 murine helper T cells
179 -cell transcriptomic analyses of bone marrow myeloid progenitor cell populations indicated a dramatic
180 Finally, overexpression of AML-1-ETO in myeloid progenitor cells prevented granulocyte colony-st
182 o more pronounced suppression of bone marrow myeloid progenitor cell proliferation and monocytosis, a
183 leukemia is preceded by a period of extended myeloid progenitor cell proliferation and self-renewal.
184 G-CSF signaling in the regulation of marrow myeloid progenitor cell proliferation in mice with Strep
186 ly test whether G-CSF can compensate for the myeloid progenitor cell reduction in the T(-) model of h
187 ia with a significant expansion of committed myeloid progenitor cells, resembling human myelodysplast
188 We determined that expression of Mll-Ell in myeloid progenitor cells resulted in autocrine productio
189 get binding to normal hematopoietic stem and myeloid progenitor cells, resulting in adverse hemato-to
190 s, we demonstrated that AML EVs are taken-up myeloid progenitor cells, resulting in the selective pro
191 wth factor 2 (Fgf2) by HoxA10-overexpressing myeloid progenitor cells results in activation of beta-c
193 ed and sufficient for the immortalization of myeloid progenitor cells, shares strong similarities to
194 lin-stimulated processes in 32D(IR) cells, a myeloid progenitor cell stably overexpressing the insuli
195 induced IL-2Ralpha mRNA expression using 32D myeloid progenitor cells stably transfected with either
196 of p53 in limiting aberrant self-renewal of myeloid progenitor cells, such that loss of p53 counters
197 d the apoptotic and growth properties of 32D myeloid progenitor cells, suggesting DeltaTrkA may have
198 llular effects were consistent with enhanced myeloid progenitor cell survival by SDF-1 alpha after de
200 oxidase (MPO), an enzyme found in developing myeloid progenitor cells, the likely origin for myeloid
201 Nf1) increases the proliferative response of myeloid progenitor cell to hematopoietic cytokines.
203 ed that differentiation of latently infected myeloid progenitor cells to dendritic or macrophage-like
204 Mcl1 facilitates AML development by allowing myeloid progenitor cells to evade Myc-induced cell death
205 hich is characterized by hypersensitivity of myeloid progenitor cells to granulocyte macrophage colon
206 JMML is acquired hypersensitivity by clonal myeloid progenitor cells to granulocyte macrophage-colon
207 pression enhanced the sensitivity of primary myeloid progenitor cells to granulocyte-macrophage colon
208 nal activators involved in the commitment of myeloid progenitor cells to the DC lineage and predicted
209 that traumatic injury induced recruitment of myeloid progenitor cells to the sprouting axons of senso
210 mitogenic response of M07e cells and murine myeloid progenitor cells to these cytokines and particul
211 mirrored by impairment of the ability of 32D myeloid progenitor cells to undergo proper terminal diff
212 tion-induced adaptation of hematopoietic and myeloid progenitor cells toward enhanced myelopoiesis mi
215 and colleagues examine deletion of Dicer1 in myeloid progenitor cells using a conditional Cebpa-Cre a
216 the enhanced self-renewal of early postnatal myeloid progenitor cells was limited and did not result
217 tand the pattern of gene expression in mouse myeloid progenitor cells, we carried out a genome-wide a
218 and induced trafficking and proliferation of myeloid progenitor cells were disordered in -/- mice.
223 ucing transcription factors IRF8 and PU.1 in myeloid progenitor cells, whereas it reduces G-CSF-drive
225 leen and liver, and the presence of immature myeloid progenitor cells with high nucleus-to-cytoplasm
226 lso compared the expression of mouse Gr-1(+) myeloid progenitor cells with that of mouse brain tissue
227 ated in interleukin 3 (IL-3)-dependent 32D.3 myeloid progenitor cells, yet this induces apoptosis whe